PETALING JAYA: Nova Pharma Solutions Bhd
(NPS) has accepted a letter of acceptance from the National Institutes of Biotechnology Malaysia (NIBM) to undertake equipment procurement and facility upgrade for NBIM’s national vaccine production development and enhancement programme.
In a filing with Bursa Malaysia, NPS said the project will take place at the Malaysia Genome and Vaccine Institute, which is located within NIBM's premises in Kajang, Selangor.
